GSK plc
GSK
$51.84
-$0.53-1.01%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 131.02% | 128.01% | -13.09% | -29.53% | -46.81% |
| Total Depreciation and Amortization | -8.34% | 17.65% | 47.97% | 32.62% | 15.38% |
| Total Amortization of Deferred Charges | 8.28% | 7.16% | 7.16% | 7.16% | 7.16% |
| Total Other Non-Cash Items | 42.45% | 705.07% | 785,582.16% | 344.37% | 203.35% |
| Change in Net Operating Assets | -749.51% | -215.12% | -159.95% | -174.30% | 137.46% |
| Cash from Operations | 22.17% | 8.83% | 6.80% | -10.29% | -0.79% |
| Capital Expenditure | 0.20% | -1.41% | -1.18% | -4.15% | -9.37% |
| Sale of Property, Plant, and Equipment | -61.58% | 573.08% | 230.74% | 200.96% | 138.58% |
| Cash Acquisitions | -113.48% | -134.05% | -6.20% | 58.53% | 43.12% |
| Divestitures | -56.85% | -73.25% | -105.22% | -131.34% | -137.24% |
| Other Investing Activities | -233.00% | -165.01% | -159.13% | -101.46% | -15.45% |
| Cash from Investing | -248.40% | -3,618.95% | -1,043.99% | -69.43% | 19.54% |
| Total Debt Issued | 138.18% | 382.68% | 300.74% | 1,138.91% | 501.35% |
| Total Debt Repaid | 29.42% | -0.43% | -23.56% | 13.76% | 2.04% |
| Issuance of Common Stock | -25.00% | -33.33% | -25.00% | -36.36% | 66.67% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.32% | -8.63% | -8.80% | -11.71% | -11.75% |
| Other Financing Activities | -12.53% | -44.70% | -7.66% | -11.83% | -8.72% |
| Cash from Financing | 17.15% | 47.55% | 52.37% | 54.87% | 14.29% |
| Foreign Exchange rate Adjustments | 66.09% | 133.10% | -77.31% | 45.44% | 43.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -148.12% | -2,699.00% | 352.82% | 1,343.70% | 202.46% |